AI Engines For more Details: Perplexity Kagi Labs You
Gastrointestinal Health: Lactobacillus gasseri is known to promote gastrointestinal health by helping to maintain a healthy balance of gut bacteria. It can potentially alleviate symptoms of conditions such as irritable bowel syndrome (IBS), diarrhea, and constipation.
Immune Function: Probiotics, including Lactobacillus gasseri, have been shown to support immune function by enhancing the body's natural defense mechanisms against infections. They may help reduce the risk of respiratory tract infections and other common illnesses.
Vaginal Health: Some research suggests that Lactobacillus gasseri may play a role in maintaining vaginal health by preventing the overgrowth of harmful bacteria and yeast. It may help reduce the risk of vaginal infections such as bacterial vaginosis and yeast infections.
Weight Management: There is evidence to suggest that certain strains of Lactobacillus, including Lactobacillus gasseri, may aid in weight management by promoting fat loss and reducing abdominal fat accumulation. However, more research is needed to fully understand its effects on weight.
Cholesterol Levels: Lactobacillus gasseri may help lower cholesterol levels by breaking down bile acids in the gut, which are involved in cholesterol metabolism. Lowering cholesterol levels can reduce the risk of heart disease.
Mental Health: Emerging research suggests that gut health may influence mental health, and probiotics like Lactobacillus gasseri may have potential benefits for mood and cognitive function. However, more studies are needed to confirm these effects.
Skin Health: Some evidence suggests that Lactobacillus gasseri may contribute to skin health by modulating the immune response and reducing inflammation. It may help alleviate symptoms of certain skin conditions such as eczema and acne.
Antibiotic-associated Diarrhea: Probiotics, including Lactobacillus gasseri, are sometimes used to prevent or alleviate diarrhea associated with antibiotic use. They can help restore the balance of gut bacteria disrupted by antibiotics.
| Rank | Probiotic | Impact |
|---|---|---|
| genus | Bifidobacterium | Increases |
| species | Bacteroides uniformis | Reduces |
| species | Bifidobacterium adolescentis | Increases |
| species | Bifidobacterium animalis | Increases |
| species | Bifidobacterium bifidum | Increases |
| species | Bifidobacterium breve | Increases |
| species | Bifidobacterium catenulatum | Increases |
| species | Bifidobacterium longum | Increases |
| species | Bifidobacterium pseudocatenulatum | Increases |
| species | Bifidobacterium pseudolongum | Increases |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
| 📓 Direct Citations | 👪👶 Indirect Citations | Taxonomy | Rank | Effect |
|---|---|---|---|---|
| 8 | 1 | Escherichia coli | species | Decreases |
| 4 | 0 | Candida albicans | species | Decreases |
| 4 | 0 | Gardnerella vaginalis | species | Decreases |
| 4 | 0 | Staphylococcus aureus | species | Decreases |
| 3 | 0 | Bifidobacterium | genus | Increases |
| 2 | 0 | Bacteroides | genus | Decreases |
| 2 | 0 | Clostridium | genus | Decreases |
| 2 | 0 | Streptococcus | genus | Increases |
| 2 | 0 | Lactobacillus | genus | Increases |
| 1 | 8 | Escherichia | genus | Decreases |
| 1 | 2 | Bifidobacteriaceae | family | Decreases |
| 1 | 1 | Clostridiaceae | family | Decreases |
| 1 | 1 | Streptococcaceae | family | Increases |
| 1 | 1 | Actinomycetaceae | family | Increases |
| 1 | 1 | Porphyromonas | genus | Increases |
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
| Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
|---|---|---|---|
| Abdominal Aortic Aneurysm | 0.2 | 0.2 | 0 |
| Acne | 5.2 | 0.9 | 4.78 |
| Addison's Disease (hypocortisolism) | 0.5 | 0.5 | |
| ADHD | 4.9 | 3.5 | 0.4 |
| Age-Related Macular Degeneration and Glaucoma | 1 | 1 | |
| Allergic Rhinitis (Hay Fever) | 5 | 3.2 | 0.56 |
| Allergies | 9.6 | 9 | 0.07 |
| Allergy to milk products | 4.9 | 2.3 | 1.13 |
| Alopecia (Hair Loss) | 1.7 | 2.3 | -0.35 |
| Alzheimer's disease | 11.8 | 8.7 | 0.36 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.217 ]